Verition Fund Management
RCUS icon

Verition Fund Management’s Arcus Biosciences RCUS Stock Holding History

Verition Fund Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,056
Closed -$502K – 3308
2025
Q4 		$502K Sell
21,056
-23,316
-53% -$476K ﹤0.01% 2654
2025
Q3 		$603K Sell
44,372
-28,937
-39% -$301K ﹤0.01% 2908
2025
Q2 		$597K Buy
73,309
+3,840
+6% +$32.8K ﹤0.01% 2825
2025
Q1 		$545K Buy
69,469
+54,132
+353% +$628K ﹤0.01% 2535
2024
Q4 		$228K Buy
+15,337
New +$250K ﹤0.01% 2923
2024
Q3 		– Sell
-89,611
Closed -$1.36M – 3468
2024
Q2 		$1.36M Buy
+89,611
New +$1.45M 0.01% 1490
2023
Q4 		– Sell
-17,668
Closed -$317K – 2622
2023
Q3 		$317K Buy
+17,668
New +$355K ﹤0.01% 1698
2023
Q2 		– Sell
-357,986
Closed -$6.53M – 2476
2023
Q1 		$6.53M Buy
357,986
+332,146
+1,285% +$6.35M 0.09% 290
2022
Q4 		$534K Buy
25,840
+17,004
+192% +$468K 0.01% 1207
2022
Q3 		$231K Sell
8,836
-141,660
-94% -$3.75M ﹤0.01% 2411
2022
Q2 		$3.81M Buy
+150,496
New +$3.69M 0.08% 359
2022
Q1 		– Sell
-11,455
Closed -$464K – 2974
2021
Q4 		$464K Buy
+11,455
New +$444K ﹤0.01% 1750
2020
Q3 		– Sell
-39,167
Closed -$969K – 1314
2020
Q2 		$969K Sell
39,167
-235,403
-86% -$6.35M 0.03% 422
2020
Q1 		$3.81M Buy
+274,570
New +$3.41M 0.15% 103

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Verition Fund Management's RCUS Position: Q1 2026 in Review

Verition Fund Management sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 21,056 shares — an estimated $502K sold.

Verition Fund Management first reported a position in RCUS in Q1 2020 and held it in 14 quarters. The position peaked at $6.53M in Q1 2023. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Verition Fund Management reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 21,056 Arcus Biosciences shares in Q1 2026, an estimated $502K.
  • Verition Fund Management first reported a position in Arcus Biosciences in Q1 2020 and held it in 14 quarters.
  • Verition Fund Management's Arcus Biosciences position peaked at $6.53M in Q1 2023.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.